Watchlist Price Alert

Telix Pharmaceuticals Lim... (TLX)

NASDAQ: TLX · Real-Time Price · USD

16.48

0.40 (2.49%)

At close: Jul 02, 2025, 9:33 AM

Telix Pharmaceuticals Cash Flow Statement

Financials in AUD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	n/a	n/a	n/a	n/a	n/a	-1.99M	-6.66M	-3.7M	-847.82K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	1.61M	1.67M	1.69M	2.42M
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	n/a	n/a	n/a	n/a	11.62M	-4.72M	-2.83M	-1.76M
Other Non-Cash Items	n/a	n/a	n/a	n/a	n/a	-13.45M	7.31M	2.81M	-553.65K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	n/a	n/a	n/a	7.67M	-3.85M	-2.29M	-2.12M
Operating Cash Flow	n/a	n/a	n/a	n/a	n/a	-6.16M	-1.52M	-1.05M	-1.07M
Capital Expenditures	-34.03M	-10.79M	-13.86M	-1.34M	-322K	-535.27K	-198.73K	-246.95K	-2.83M
Cash Acquisitions	-34.69M	n/a	-973K	n/a	-322K	n/a	n/a	n/a	n/a
Purchase of Investments	-51.99M	-13.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-34.17M	-1.54M	-2.16M	-1.39M	-447K	-62.47K	n/a	-756.44K	914.43K
Investing Cash Flow	-135.17M	-25.49M	-17M	-2.73M	-1.09M	-597.74K	-198.73K	-1M	-1.91M
Debt Repayment	652.81M	5.76M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-7.82M	n/a	-130K	-759.6K	-1.03M	n/a	-840.89K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-14.88M	-2.22M	174.96M	2.85M	34.12M	6.42M	1.3M	2.23M	3.05M
Financial Cash Flow	638.92M	10.19M	174.96M	2.85M	34.12M	6.42M	1.3M	2.23M	3.05M
Net Cash Flow	587.11M	6.91M	94.29M	-55.91M	33.35M	-1.54M	-405.98K	183.26K	81.87K
Free Cash Flow	9M	-10.79M	-13.86M	-1.34M	-322K	-6.69M	-1.71M	-1.3M	-3.9M